OROPRO

OROPRO is a **cryopreserved human umbilical cord and Wharton's jelly tissue allograft** intended for homologous supplementation as a cushioning and supportive biologic matrix. It is described as an aseptically processed perinatal connective tissue allograft designed to preserve endogenous cytokines, growth factors, extracellular matrix components, and other naturally occurring proteins, and has also been described as containing mesenchymal stem cells. Rather than acting through a single defined molecular target, OROPRO appears to function as an injectable flowable tissue matrix that provides local biomechanical cushioning and structural support while delivering a complex regenerative microenvironment associated with anti-inflammatory, anti-microbial, anti-fibrotic, and wound-healing activity. Based on the provided context, it is best characterized as a tissue allograft biologic product rather than a conventional pharmaceutical drug.

Brand names

OROPRO

Other names

cryopreserved human umbilical cord tissue allograftcryopreserved human perinatal tissue allograftcryopreserved umbilical cord and Wharton's jelly connective tissue allograftinjectable flowable tissue matrix